Literature DB >> 28275073

Rapid Detection of Cell-Free Mycobacterium tuberculosis DNA in Tuberculous Pleural Effusion.

Nanying Che1, Xinting Yang2, Zichen Liu3, Kun Li3, Xiaoyou Chen4.   

Abstract

Tuberculous pleurisy is one of the most common types of extrapulmonary tuberculosis, but its diagnosis remains difficult. In this study, we report for the first time on the detection of cell-free Mycobacterium tuberculosis DNA in pleural effusion and an evaluation of a newly developed molecular assay for the detection of cell-free Mycobacterium tuberculosis DNA. A total of 78 patients with pleural effusion, 60 patients with tuberculous pleurisy, and 18 patients with alternative diseases were included in this study. Mycobacterial culture, the Xpert MTB/RIF assay, the adenosine deaminase assay, the T-SPOT.TB assay, and the cell-free Mycobacterium tuberculosis DNA assay were performed on all the pleural effusion samples. The cell-free Mycobacterium tuberculosis DNA assay and adenosine deaminase assay showed significantly higher sensitivities of 75.0% and 68.3%, respectively, than mycobacterial culture and the Xpert MTB/RIF assay, which had sensitivities of 26.7% and 20.0%, respectively (P < 0.01). All four of these tests showed good specificities: 88.9% for the adenosine deaminase assay and 100% for the remaining three assays. The T-SPOT.TB assay with pleural effusion showed the highest sensitivity of 95.0% but the lowest specificity of 38.9%. The cell-free Mycobacterium tuberculosis DNA assay detected as few as 1.25 copies of IS6110 per ml of pleural effusion and showed good accordance of the results between repeated tests (r = 0.978, P = 2.84 × 10-10). These data suggest that the cell-free Mycobacterium tuberculosis DNA assay is a rapid and accurate molecular test which provides direct evidence of Mycobacterium tuberculosis etiology.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  Mycobacterium tuberculosis; cell-free DNA; pleural effusion

Mesh:

Substances:

Year:  2017        PMID: 28275073      PMCID: PMC5405270          DOI: 10.1128/JCM.02473-16

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  30 in total

1.  [Not Available].

Authors:  P MANDEL; P METAIS
Journal:  C R Seances Soc Biol Fil       Date:  1948-02

Review 2.  Interferon Gamma Release Assays for Diagnosis of Pleural Tuberculosis: a Systematic Review and Meta-Analysis.

Authors:  Ashutosh N Aggarwal; Ritesh Agarwal; Dheeraj Gupta; Sahajal Dhooria; Digambar Behera
Journal:  J Clin Microbiol       Date:  2015-05-20       Impact factor: 5.948

3.  Evaluating pleural ADA, ADA2, IFN-γ and IGRA for diagnosing tuberculous pleurisy.

Authors:  Li-Ta Keng; Chin-Chung Shu; Jason Yao-Ping Chen; Sheng-Kai Liang; Ching-Kai Lin; Lih-Yu Chang; Chia-Hao Chang; Jann-Yuan Wang; Chong-Jen Yu; Li-Na Lee
Journal:  J Infect       Date:  2013-06-22       Impact factor: 6.072

Review 4.  The translational potential of circulating tumour DNA in oncology.

Authors:  K M Patel; D W Y Tsui
Journal:  Clin Biochem       Date:  2015-04-15       Impact factor: 3.281

Review 5.  Diagnosis of tuberculosis pleurisy with adenosine deaminase (ADA): a systematic review and meta-analysis.

Authors:  Xuwei Gui; Heping Xiao
Journal:  Int J Clin Exp Med       Date:  2014-10-15

6.  Utility of quantitative T-cell responses versus unstimulated interferon-{gamma} for the diagnosis of pleural tuberculosis.

Authors:  K Dheda; R N van Zyl-Smit; L A Sechi; M Badri; R Meldau; S Meldau; G Symons; P L Semple; A Maredza; R Dawson; H Wainwright; A Whitelaw; Y Vallie; P Raubenheimer; E D Bateman; A Zumla
Journal:  Eur Respir J       Date:  2009-04-22       Impact factor: 16.671

7.  Adenosine deaminase and interferon gamma measurements for the diagnosis of tuberculous pleurisy: a meta-analysis.

Authors:  S Greco; E Girardi; R Masciangelo; G B Capoccetta; C Saltini
Journal:  Int J Tuberc Lung Dis       Date:  2003-08       Impact factor: 2.373

Review 8.  Tuberculous pleural effusion.

Authors:  José M Porcel
Journal:  Lung       Date:  2009-08-13       Impact factor: 2.584

Review 9.  Diagnostic accuracy of adenosine deaminase in tuberculous pleurisy: a meta-analysis.

Authors:  Qiu-Li Liang; Huan-Zhong Shi; Ke Wang; Shou-Ming Qin; Xue-Jun Qin
Journal:  Respir Med       Date:  2008-01-28       Impact factor: 3.415

10.  Elevated levels of circulating DNA in cardiovascular disease patients: metagenomic profiling of microbiome in the circulation.

Authors:  Vasudevan Dinakaran; Andiappan Rathinavel; Muthuirulan Pushpanathan; Ramamoorthy Sivakumar; Paramasamy Gunasekaran; Jeyaprakash Rajendhran
Journal:  PLoS One       Date:  2014-08-18       Impact factor: 3.240

View more
  5 in total

1.  Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults.

Authors:  Mikashmi Kohli; Ian Schiller; Nandini Dendukuri; Mandy Yao; Keertan Dheda; Claudia M Denkinger; Samuel G Schumacher; Karen R Steingart
Journal:  Cochrane Database Syst Rev       Date:  2021-01-15

2.  Xpert MTB/RIF Ultra versus Xpert MTB/RIF for diagnosis of tuberculous pleural effusion: A systematic review and comparative meta-analysis.

Authors:  Ashutosh Nath Aggarwal; Ritesh Agarwal; Sahajal Dhooria; Kuruswamy Thurai Prasad; Inderpaul Singh Sehgal; Valliappan Muthu
Journal:  PLoS One       Date:  2022-07-11       Impact factor: 3.752

Review 3.  Xpert® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance.

Authors:  Mikashmi Kohli; Ian Schiller; Nandini Dendukuri; Keertan Dheda; Claudia M Denkinger; Samuel G Schumacher; Karen R Steingart
Journal:  Cochrane Database Syst Rev       Date:  2018-08-27

4.  Is Xpert MTB/RIF appropriate for diagnosing tuberculous pleurisy with pleural fluid samples? A systematic review.

Authors:  Zhen-Yu Huo; Li Peng
Journal:  BMC Infect Dis       Date:  2018-06-25       Impact factor: 3.090

5.  Accuracy of Xpert MTB/RIF assay for the diagnosis of tuberculous pleural effusion.

Authors:  Yi-Ran Qiu; Yu-Yan Chen; Xin-Ran Wu; Ya-Ping Li; Xun-Jie Cao; Zi-Yuan Yu; Min Lin; Qiu-Yin Li; Ji-Chun Chen; Xin Yin; Shu-Chang Weng; Xu-Guang Guo
Journal:  J Clin Lab Anal       Date:  2021-12-17       Impact factor: 2.352

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.